APA (7th ed.) Citation

AC, R., B, W., T, S., SE, K., LH, L., K, W., . . . MH, O. (2012). Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Journal of hypertension, 30(6), 1252. https://doi.org/10.1097/HJH.0b013e328352f7f6

Chicago Style (17th ed.) Citation

AC, Ruwald, et al. "Losartan Versus Atenolol-based Antihypertensive Treatment Reduces Cardiovascular Events Especially Well in Elderly Patients: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study." Journal of Hypertension 30, no. 6 (2012): 1252. https://doi.org/10.1097/HJH.0b013e328352f7f6.

MLA (9th ed.) Citation

AC, Ruwald, et al. "Losartan Versus Atenolol-based Antihypertensive Treatment Reduces Cardiovascular Events Especially Well in Elderly Patients: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study." Journal of Hypertension, vol. 30, no. 6, 2012, p. 1252, https://doi.org/10.1097/HJH.0b013e328352f7f6.